Here, we extended this model for CPVT-related mutations and characterized the role of RyR2- and CASQ2-mutations in C. elegans pumping, including homologous mutations causing CPVT in humans. The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.